Literature DB >> 8886083

A new approach to the treatment of osteoarthritis: viscosupplementation.

J G Peyron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8886083     DOI： 10.1016/s1063-4584(05)80022-6

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN： 1063-4584            Impact factor:   6.576


× No keyword cloud information.
  6 in total

1.  Hyaluronic acid injections for osteoarthritis of the knee: predictors of successful treatment.

Authors:  Eric N Bowman; Justin D Hallock; Thomas W Throckmorton; Fredrick M Azar
Journal:  Int Orthop       Date:  2018-01-03       Impact factor: 3.075

Review 2.  Disease-modifying therapies for osteoarthritis : current status.

Authors:  Marc Fajardo; Paul E Di Cesare
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Effects of Viscoseal, a synovial fluid substitute, on recovery after arthroscopic partial meniscectomy and joint lavage.

Authors:  B Mathies
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-05-26       Impact factor: 4.342

4.  Frictional characterization of injectable hyaluronic acids is more predictive of clinical outcomes than traditional rheological or viscoelastic characterization.

Authors:  Edward D Bonnevie; Devis Galesso; Cynthia Secchieri; Lawrence J Bonassar
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

5.  Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis.

Authors:  T Pham; A Le Henanff; Ph Ravaud; P Dieppe; L Paolozzi; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-08-26       Impact factor: 19.103

6.  Gait patterns after intraarticular treatment of patients with osteoarthritis of the knee--hyaluronan versus triamcinolone: a prospective, randomized, doubleblind, monocentric study.

Authors:  A Skwara; R Ponelis; C O Tibesku; D Rosenbaum; S Fuchs-Winkelmann
Journal:  Eur J Med Res       Date:  2009-04-16       Impact factor: 2.175
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.